Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis.

Balu R, McCracken L, Lancaster E, Graus F, Dalmau J, Titulaer MJ.

Neurology. 2019 Jan 15;92(3):e244-e252. doi: 10.1212/WNL.0000000000006783. Epub 2018 Dec 21.

2.

AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated Toxicity.

Amado DA, Rieders JM, Diatta F, Hernandez-Con P, Singer A, Mak JT, Zhang J, Lancaster E, Davidson BL, Chen-Plotkin AS.

Mol Ther. 2019 Feb 6;27(2):465-478. doi: 10.1016/j.ymthe.2018.11.013. Epub 2018 Nov 17.

PMID:
30559071
3.

Gain of Function for the SCN1A/hNav1.1-L1670W Mutation Responsible for Familial Hemiplegic Migraine.

Dhifallah S, Lancaster E, Merrill S, Leroudier N, Mantegazza M, Cestèle S.

Front Mol Neurosci. 2018 Jul 9;11:232. doi: 10.3389/fnmol.2018.00232. eCollection 2018.

4.

Anti-NMDAR encephalitis in a patient with Crohn disease receiving adalimumab.

Noble GP, Lancaster E.

Neurol Neuroimmunol Neuroinflamm. 2018 Jul 2;5(5):e476. doi: 10.1212/NXI.0000000000000476. eCollection 2018 Sep. No abstract available.

5.

Isotype-Switched Autoantibodies Are Necessary To Facilitate Central Nervous System Autoimmune Disease in Aicda-/- and Ung-/- Mice.

Galicia G, Lee DSW, Ramaglia V, Ward LA, Yam JY, Leung LYT, Li R, Handy M, Zhang J, Drohomyrecky PC, Lancaster E, Bar-Or A, Martin A, Gommerman JL.

J Immunol. 2018 Aug 15;201(4):1119-1130. doi: 10.4049/jimmunol.1700729. Epub 2018 Jul 6.

PMID:
29980612
6.

Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E.

Lancaster E, Li J, Hanania T, Liem R, Scheideler MA, Scherer SS.

Exp Neurol. 2018 Oct;308:13-25. doi: 10.1016/j.expneurol.2018.06.010. Epub 2018 Jun 22.

PMID:
29940160
7.

Strategies to Reduce the Euthanasia of Impounded Dogs and Cats Used by Councils in Victoria, Australia.

Rand J, Lancaster E, Inwood G, Cluderay C, Marston L.

Animals (Basel). 2018 Jun 21;8(7). pii: E100. doi: 10.3390/ani8070100.

8.

Are collegiate athletes as healthy as we think they are?

Geller KS, Lancaster E, Hill C, Bettinger S.

Transl Behav Med. 2019 Jan 1;9(1):135-138. doi: 10.1093/tbm/iby039.

PMID:
29669136
9.

Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia.

Patterson KR, Dalmau J, Lancaster E.

Ann Neurol. 2018 Jan;83(1):40-51. doi: 10.1002/ana.25120. Epub 2018 Jan 10.

10.

Paraneoplastic Disorders.

Lancaster E.

Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1653-1679. doi: 10.1212/CON.0000000000000542.

PMID:
29200116
11.

Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.

Burnor E, Yang L, Zhou H, Patterson KR, Quinn C, Reilly MM, Rossor AM, Scherer SS, Lancaster E.

Neurology. 2018 Jan 2;90(1):e31-e38. doi: 10.1212/WNL.0000000000004773. Epub 2017 Nov 29.

12.

Improving the antibody-based evaluation of autoimmune encephalitis.

McCracken L, Zhang J, Greene M, Crivaro A, Gonzalez J, Kamoun M, Lancaster E.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 11;4(6):e404. doi: 10.1212/NXI.0000000000000404. eCollection 2017 Nov.

13.

CNS syndromes associated with antibodies against metabotropic receptors.

Lancaster E.

Curr Opin Neurol. 2017 Jun;30(3):354-360. doi: 10.1097/WCO.0000000000000448. Review.

PMID:
28306571
14.

Serum neuronal cell-surface antibodies in first-episode psychosis.

Leypoldt F, de Witte L, Lancaster E, Titulaer MJ.

Lancet Psychiatry. 2017 Mar;4(3):186-187. doi: 10.1016/S2215-0366(17)30043-3. No abstract available.

PMID:
28236946
15.

Delta/Notch-Like EGF-Related Receptor (DNER) Is Not a Notch Ligand.

Greene M, Lai Y, Pajcini K, Bailis W, Pear WS, Lancaster E.

PLoS One. 2016 Sep 13;11(9):e0161157. doi: 10.1371/journal.pone.0161157. eCollection 2016.

16.

Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.

Ariño H, Armangué T, Petit-Pedrol M, Sabater L, Martinez-Hernandez E, Hara M, Lancaster E, Saiz A, Dalmau J, Graus F.

Neurology. 2016 Aug 23;87(8):759-65. doi: 10.1212/WNL.0000000000003009. Epub 2016 Jul 27.

17.

The clinical spectrum of Caspr2 antibody-associated disease.

van Sonderen A, Ariño H, Petit-Pedrol M, Leypoldt F, Körtvélyessy P, Wandinger KP, Lancaster E, Wirtz PW, Schreurs MW, Sillevis Smitt PA, Graus F, Dalmau J, Titulaer MJ.

Neurology. 2016 Aug 2;87(5):521-8. doi: 10.1212/WNL.0000000000002917. Epub 2016 Jul 1.

18.

Modeling Interventions in the Owned Cat Population to Decrease Numbers, Knox County, TN.

Lancaster EP, Lenhart S, Ojogbo EJ, Rekant SI, Scott JR, Weimer H, New JC Jr.

J Appl Anim Welf Sci. 2016 Oct-Dec;19(4):396-407. doi: 10.1080/10888705.2016.1176923. Epub 2016 May 6.

PMID:
27152694
19.

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.

Martinez-Hernandez E, Ariño H, McKeon A, Iizuka T, Titulaer MJ, Simabukuro MM, Lancaster E, Petit-Pedrol M, Planagumà J, Blanco Y, Harvey RJ, Saiz A, Graus F, Dalmau J.

JAMA Neurol. 2016 Jun 1;73(6):714-20. doi: 10.1001/jamaneurol.2016.0133.

20.

Reck enables cerebrovascular development by promoting canonical Wnt signaling.

Ulrich F, Carretero-Ortega J, Menéndez J, Narvaez C, Sun B, Lancaster E, Pershad V, Trzaska S, Véliz E, Kamei M, Prendergast A, Kidd KR, Shaw KM, Castranova DA, Pham VN, Lo BD, Martin BL, Raible DW, Weinstein BM, Torres-Vázquez J.

Development. 2016 Mar 15;143(6):1055. doi: 10.1242/dev.136507. No abstract available.

21.

A clinical approach to diagnosis of autoimmune encephalitis.

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J.

Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9. Epub 2016 Feb 20. Review.

22.

Subtype-specific therapy for autoimmune neuropathies?

Lancaster E, Scherer SS.

Neurol Neuroimmunol Neuroinflamm. 2015 Sep 24;2(5):e152. doi: 10.1212/NXI.0000000000000152. eCollection 2015 Oct. No abstract available.

23.

The Diagnosis and Treatment of Autoimmune Encephalitis.

Lancaster E.

J Clin Neurol. 2016 Jan;12(1):1-13. doi: 10.3988/jcn.2016.12.1.1. Review.

24.

Reck enables cerebrovascular development by promoting canonical Wnt signaling.

Ulrich F, Carretero-Ortega J, Menéndez J, Narvaez C, Sun B, Lancaster E, Pershad V, Trzaska S, Véliz E, Kamei M, Prendergast A, Kidd KR, Shaw KM, Castranova DA, Pham VN, Lo BD, Martin BL, Raible DW, Weinstein BM, Torres-Vázquez J.

Development. 2016 Jan 1;143(1):147-59. doi: 10.1242/dev.123059. Epub 2015 Dec 10. Erratum in: Development. 2016 Mar 15;143(6):1055.

25.

Problems Associated with the Microchip Data of Stray Dogs and Cats Entering RSPCA Queensland Shelters.

Lancaster E, Rand J, Collecott S, Paterson M.

Animals (Basel). 2015 May 13;5(2):332-48. doi: 10.3390/ani5020332.

26.

A Targeted Swallow Screen for the Detection of Postoperative Dysphagia.

Gee E, Lancaster E, Meltzer J, Mendelsohn AH, Benharash P.

Am Surg. 2015 Oct;81(10):979-82.

PMID:
26463293
27.

Caspr2 autoantibodies target multiple epitopes.

Olsen AL, Lai Y, Dalmau J, Scherer SS, Lancaster E.

Neurol Neuroimmunol Neuroinflamm. 2015 Jul 2;2(4):e127. doi: 10.1212/NXI.0000000000000127. eCollection 2015 Aug.

28.

Diagnosing Encephalitis, Not Otherwise Specified.

Wang ZL, Lancaster E, Yang L.

JAMA Neurol. 2015 Jun;72(6):725. doi: 10.1001/jamaneurol.2015.0542. No abstract available.

PMID:
26053445
29.

Diagnostic Value and Safety of Brain Biopsy in Patients With Cryptogenic Neurological Disease: A Systematic Review and Meta-analysis of 831 Cases.

Bai HX, Zou Y, Lee AM, Lancaster E, Yang L.

Neurosurgery. 2015 Aug;77(2):283-95; discussion 295. doi: 10.1227/NEU.0000000000000756. Review.

PMID:
25856111
30.

Paraneoplastic disorders.

Lancaster E.

Continuum (Minneap Minn). 2015 Apr;21(2 Neuro-oncology):452-75. doi: 10.1212/01.CON.0000464180.89580.88. Review.

31.

Assessing the incidence of anti-NMDAR encephalitis.

Greene M, Lancaster E.

Arch Dis Child. 2015 Jun;100(6):512-3. doi: 10.1136/archdischild-2014-307978. Epub 2015 Mar 25. No abstract available.

32.

Acetaminophen hepatotoxicity: an updated review.

Lancaster EM, Hiatt JR, Zarrinpar A.

Arch Toxicol. 2015 Feb;89(2):193-9. doi: 10.1007/s00204-014-1432-2. Epub 2014 Dec 24. Review.

33.

Paraneoplastic disorders in thymoma patients.

Evoli A, Lancaster E.

J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S143-7. doi: 10.1097/JTO.0000000000000300. Review.

34.

Paraneoplastic cerebellar degeneration associated with noncutaneous Merkel cell carcinoma.

Zhang C, Emery L, Lancaster E.

Neurol Neuroimmunol Neuroinflamm. 2014 Jul 3;1(2):e17. doi: 10.1212/NXI.0000000000000017. eCollection 2014 Aug. No abstract available.

35.

Immunoglobulin G antibodies to the N-Methyl-D-aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses.

Lancaster E, Leypoldt F, Titulaer MJ, Honnorat J, Waters PJ, Reindl M, Höftberger R.

Ann Neurol. 2015 Jan;77(1):183. doi: 10.1002/ana.24233. Epub 2014 Dec 4. No abstract available.

36.

Therapeutic plasma exchange and immunosuppressive therapy in a patient with anti-GAD antibody-related epilepsy: quantification of the antibody response.

Farooqi MS, Lai Y, Lancaster E, Schmitt SE, Sachais BS.

J Clin Apher. 2015 Feb;30(1):8-14. doi: 10.1002/jca.21342. Epub 2014 Jun 25.

PMID:
24961613
37.

Antibodies to Delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma.

Greene M, Lai Y, Baella N, Dalmau J, Lancaster E.

JAMA Neurol. 2014 Aug;71(8):1003-8. doi: 10.1001/jamaneurol.2014.999.

38.

Kv7.2 regulates the function of peripheral sensory neurons.

King CH, Lancaster E, Salomon D, Peles E, Scherer SS.

J Comp Neurol. 2014 Oct 1;522(14):3262-80. doi: 10.1002/cne.23595. Epub 2014 Apr 12.

39.
40.

Acute care surgery in heart transplant recipients.

Ashman Z, Lancaster E, Satou N, Shemin RJ, Hiatt JR, Benharash P.

Am Surg. 2013 Oct;79(10):973-6.

PMID:
24160781
41.

Qualitative factors in patients who die shortly after emergency department discharge.

Gabayan GZ, Sun BC, Asch SM, Timmermans S, Sarkisian C, Yiu S, Lancaster EM, Poon KT, Kellermann AL, Ryan G, Miniel NJ, Flansbaum D, Hoffman JR, Derose SF.

Acad Emerg Med. 2013 Aug;20(8):778-85. doi: 10.1111/acem.12181.

42.

Acquired neuromyotonia heralding recurrent thymoma in myasthenia gravis.

Fleisher J, Richie M, Price R, Scherer S, Dalmau J, Lancaster E.

JAMA Neurol. 2013 Oct;70(10):1311-4.

43.

Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype.

McKeon A, Martinez-Hernandez E, Lancaster E, Matsumoto JY, Harvey RJ, McEvoy KM, Pittock SJ, Lennon VA, Dalmau J.

JAMA Neurol. 2013 Jan;70(1):44-50. doi: 10.1001/jamaneurol.2013.574.

44.

Neuronal autoantigens--pathogenesis, associated disorders and antibody testing.

Lancaster E, Dalmau J.

Nat Rev Neurol. 2012 Jun 19;8(7):380-90. doi: 10.1038/nrneurol.2012.99. Review.

45.

Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome.

Lancaster E, Martinez-Hernandez E, Titulaer MJ, Boulos M, Weaver S, Antoine JC, Liebers E, Kornblum C, Bien CG, Honnorat J, Wong S, Xu J, Contractor A, Balice-Gordon R, Dalmau J.

Neurology. 2011 Nov 1;77(18):1698-701. doi: 10.1212/WNL.0b013e3182364a44. Epub 2011 Oct 19.

46.

Patterns and predictors of short-term death after emergency department discharge.

Gabayan GZ, Derose SF, Asch SM, Yiu S, Lancaster EM, Poon KT, Hoffman JR, Sun BC.

Ann Emerg Med. 2011 Dec;58(6):551-558.e2. doi: 10.1016/j.annemergmed.2011.07.001. Epub 2011 Jul 29.

47.

Encephalitis and antibodies to synaptic and neuronal cell surface proteins.

Lancaster E, Martinez-Hernandez E, Dalmau J.

Neurology. 2011 Jul 12;77(2):179-89. doi: 10.1212/WNL.0b013e318224afde. Review.

48.

Herpes simplex virus hepatitis - it's high time we consider empiric treatment.

Navaneethan U, Lancaster E, Venkatesh PG, Wang J, Neff GW.

J Gastrointestin Liver Dis. 2011 Mar;20(1):93-6.

49.

Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia.

Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, Martinez-Hernandez E, Wilson C, Jacobs D, Lai M, Walker RW, Graus F, Bataller L, Illa I, Markx S, Strauss KA, Peles E, Scherer SS, Dalmau J.

Ann Neurol. 2011 Feb;69(2):303-11. doi: 10.1002/ana.22297.

50.

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R.

Lancet Neurol. 2011 Jan;10(1):63-74. doi: 10.1016/S1474-4422(10)70253-2. Review.

Supplemental Content

Loading ...
Support Center